Regulation of mitogen-stimulated human T-cell proliferation, interleukin-2 production, and interleukin-2 receptor expression by protein kinase C inhibitor, H-7

Durgaprasadarao Atluru; Subhashini Polam; Subbayamma Atluru; Gayle E. Woloschak

doi:10.1016/0008-8749(90)90207-8

Regulation of mitogen-stimulated human T-cell proliferation, interleukin-2 production, and interleukin-2 receptor expression by protein kinase C inhibitor, H-7

Durgaprasadarao Atluru^*, Subhashini Polam, Subbayamma Atluru, Gayle E. Woloschak

^*Corresponding author for this work

Radiation Oncology

Research output: Contribution to journal › Article › peer-review

20 Scopus citations

Abstract

Recently published reports suggest that the activation of protein kinase C (PKC) plays an important role in the activation pathway of many cell types. In this study, we examined the role of PKC in human T-cell proliferation, IL-2 production, and IL-2R expression, when cultured with the mitogen PHA, the PKC inhibitor H-7, and H-7 control HA1004. H-7 inhibited the PHA-stimulated [³H]thymidine uptake, IL-2 production, and IL-2R expression in a dose-related manner. Further, we found H-7 inhibited T-cell proliferation, IL-2 production, and IL-2 mRNA from PHA plus PMA-stimulated cultures. We also found that H-7 inhibited the early-stage activation of PHA-stimulated cells. The presence of exogenous purified human IL-2 or rIL-4 partly reversed the immunosuppression caused by H-7. In contrast, HA1004 had no effect on cell proliferation, IL-2 production, or IL-2R expression. Our results demonstrate that PKC activation is one major pathway through which T-cells become activated.

Original language	English (US)
Pages (from-to)	310-320
Number of pages	11
Journal	Cellular Immunology
Volume	129
Issue number	2
DOIs	https://doi.org/10.1016/0008-8749(90)90207-8
State	Published - Sep 1990

Funding

’ This work was supported by a grant from the National Institutes of Health, R29CA46964 to D.A. 2 Part ofthis data was presented at 73rd FASEB Annual Meeting, New Orleans, LA; March 19-23, 1989. ’ Present address: Resident Physician, Department of Psychiatry and Behavioral Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73 190. ’ Abbreviations used: PKC, protein kinase C, IL-2, interleukin-2; IL-2R, interleukin-2 receptor; IL-3, interleukin-3, rlL-4, recombinant interleukin-4; PHA, phy-tohemagglutinin; DAG, Diacylglycerol; H-7, I-[S-lsoquinolinesulfonyl]-2-methylpiperazine dihydrochloride; HA 1004, N-[2quanidinoethyl]-5-isoqui-nolinesulfonamidehydrochloride; k,, inhibition constant; PIP*, phosphotidylinositol 4,5 biphosphate; PGEz, prostaglandin Ez; TPA, 12-O-tetradecanoylphorbol-I3-acetate; PMA, phorbol I2-myristate l3-ace.-tate.

ASJC Scopus subject areas

Immunology

Access to Document

10.1016/0008-8749(90)90207-8

Cite this

@article{6d4ca67284cf4fcd931a4b983caa0d04,

title = "Regulation of mitogen-stimulated human T-cell proliferation, interleukin-2 production, and interleukin-2 receptor expression by protein kinase C inhibitor, H-7",

abstract = "Recently published reports suggest that the activation of protein kinase C (PKC) plays an important role in the activation pathway of many cell types. In this study, we examined the role of PKC in human T-cell proliferation, IL-2 production, and IL-2R expression, when cultured with the mitogen PHA, the PKC inhibitor H-7, and H-7 control HA1004. H-7 inhibited the PHA-stimulated [3H]thymidine uptake, IL-2 production, and IL-2R expression in a dose-related manner. Further, we found H-7 inhibited T-cell proliferation, IL-2 production, and IL-2 mRNA from PHA plus PMA-stimulated cultures. We also found that H-7 inhibited the early-stage activation of PHA-stimulated cells. The presence of exogenous purified human IL-2 or rIL-4 partly reversed the immunosuppression caused by H-7. In contrast, HA1004 had no effect on cell proliferation, IL-2 production, or IL-2R expression. Our results demonstrate that PKC activation is one major pathway through which T-cells become activated.",

author = "Durgaprasadarao Atluru and Subhashini Polam and Subbayamma Atluru and Woloschak, {Gayle E.}",

note = "Funding Information: {\textquoteright} This work was supported by a grant from the National Institutes of Health, R29CA46964 to D.A. 2 Part ofthis data was presented at 73rd FASEB Annual Meeting, New Orleans, LA; March 19-23, 1989. {\textquoteright} Present address: Resident Physician, Department of Psychiatry and Behavioral Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73 190. {\textquoteright} Abbreviations used: PKC, protein kinase C, IL-2, interleukin-2; IL-2R, interleukin-2 receptor; IL-3, interleukin-3, rlL-4, recombinant interleukin-4; PHA, phy-tohemagglutinin; DAG, Diacylglycerol; H-7, I-[S-lsoquinolinesulfonyl]-2-methylpiperazine dihydrochloride; HA 1004, N-[2quanidinoethyl]-5-isoqui-nolinesulfonamidehydrochloride; k,, inhibition constant; PIP*, phosphotidylinositol 4,5 biphosphate; PGEz, prostaglandin Ez; TPA, 12-O-tetradecanoylphorbol-I3-acetate; PMA, phorbol I2-myristate l3-ace.-tate.",

year = "1990",

month = sep,

doi = "10.1016/0008-8749(90)90207-8",

language = "English (US)",

volume = "129",

pages = "310--320",

journal = "Cellular Immunology",

issn = "0008-8749",

publisher = "Academic Press Inc.",

number = "2",

}

TY - JOUR

T1 - Regulation of mitogen-stimulated human T-cell proliferation, interleukin-2 production, and interleukin-2 receptor expression by protein kinase C inhibitor, H-7

AU - Atluru, Durgaprasadarao

AU - Polam, Subhashini

AU - Atluru, Subbayamma

AU - Woloschak, Gayle E.

N1 - Funding Information: ’ This work was supported by a grant from the National Institutes of Health, R29CA46964 to D.A. 2 Part ofthis data was presented at 73rd FASEB Annual Meeting, New Orleans, LA; March 19-23, 1989. ’ Present address: Resident Physician, Department of Psychiatry and Behavioral Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73 190. ’ Abbreviations used: PKC, protein kinase C, IL-2, interleukin-2; IL-2R, interleukin-2 receptor; IL-3, interleukin-3, rlL-4, recombinant interleukin-4; PHA, phy-tohemagglutinin; DAG, Diacylglycerol; H-7, I-[S-lsoquinolinesulfonyl]-2-methylpiperazine dihydrochloride; HA 1004, N-[2quanidinoethyl]-5-isoqui-nolinesulfonamidehydrochloride; k,, inhibition constant; PIP*, phosphotidylinositol 4,5 biphosphate; PGEz, prostaglandin Ez; TPA, 12-O-tetradecanoylphorbol-I3-acetate; PMA, phorbol I2-myristate l3-ace.-tate.

PY - 1990/9

Y1 - 1990/9

N2 - Recently published reports suggest that the activation of protein kinase C (PKC) plays an important role in the activation pathway of many cell types. In this study, we examined the role of PKC in human T-cell proliferation, IL-2 production, and IL-2R expression, when cultured with the mitogen PHA, the PKC inhibitor H-7, and H-7 control HA1004. H-7 inhibited the PHA-stimulated [3H]thymidine uptake, IL-2 production, and IL-2R expression in a dose-related manner. Further, we found H-7 inhibited T-cell proliferation, IL-2 production, and IL-2 mRNA from PHA plus PMA-stimulated cultures. We also found that H-7 inhibited the early-stage activation of PHA-stimulated cells. The presence of exogenous purified human IL-2 or rIL-4 partly reversed the immunosuppression caused by H-7. In contrast, HA1004 had no effect on cell proliferation, IL-2 production, or IL-2R expression. Our results demonstrate that PKC activation is one major pathway through which T-cells become activated.

AB - Recently published reports suggest that the activation of protein kinase C (PKC) plays an important role in the activation pathway of many cell types. In this study, we examined the role of PKC in human T-cell proliferation, IL-2 production, and IL-2R expression, when cultured with the mitogen PHA, the PKC inhibitor H-7, and H-7 control HA1004. H-7 inhibited the PHA-stimulated [3H]thymidine uptake, IL-2 production, and IL-2R expression in a dose-related manner. Further, we found H-7 inhibited T-cell proliferation, IL-2 production, and IL-2 mRNA from PHA plus PMA-stimulated cultures. We also found that H-7 inhibited the early-stage activation of PHA-stimulated cells. The presence of exogenous purified human IL-2 or rIL-4 partly reversed the immunosuppression caused by H-7. In contrast, HA1004 had no effect on cell proliferation, IL-2 production, or IL-2R expression. Our results demonstrate that PKC activation is one major pathway through which T-cells become activated.

UR - http://www.scopus.com/inward/record.url?scp=0025071551&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025071551&partnerID=8YFLogxK

U2 - 10.1016/0008-8749(90)90207-8

DO - 10.1016/0008-8749(90)90207-8

M3 - Article

C2 - 2383893

AN - SCOPUS:0025071551

SN - 0008-8749

VL - 129

SP - 310

EP - 320

JO - Cellular Immunology

JF - Cellular Immunology

IS - 2

ER -

Regulation of mitogen-stimulated human T-cell proliferation, interleukin-2 production, and interleukin-2 receptor expression by protein kinase C inhibitor, H-7

Abstract

Funding

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this